Supplementary Table 4 from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
posted on 2023-03-30, 21:16authored byKrasimira Aleksandrova, Heiner Boeing, Mazda Jenab, H. Bas Bueno-de-Mesquita, Eugene Jansen, Fränzel J. B. van Duijnhoven, Sabina Rinaldi, Veronika Fedirko, Isabelle Romieu, Elio Riboli, Marc J. Gunter, Sabine Westphal, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Antoine Racine, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Rudolf Kaaks, Annekatrin Lukanova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Amalia Mattiello, Valeria Pala, Domenico Palli, Rosario Tumino, Paolo Vineis, Genevieve Buckland, María-José Sánchez, Pilar Amiano, José María Huerta, Aurelio Barricarte, Virginia Menéndez, Petra H. Peeters, Stefan Söderberg, Richard Palmqvist, Naomi E. Allen, Francesca L. Crowe, Kay-Tee Khaw, Nickolas Wareham, Tobias Pischon
PDF file - 100K, Relative risks (RR-s) and 95% confidence intervals (CI-s) of colon, rectal and colorectal cancer according to sex-specific quintiles of baseline leptin concentrations, in men and women , the European Prospective Investigation into Cancer and Nutrition (EPIC), 1992-2003